Future Care Trading Valuation
Is 9544 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 9544 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 9544 (SAR10.92) is trading above our estimate of fair value (SAR0.21)
Significantly Below Fair Value: 9544 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 9544?
Key metric: As 9544 barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is 9544's PB Ratio? | |
|---|---|
| PB Ratio | 68.5x |
| Book | ر.س78.80m |
| Market Cap | ر.س5.21b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 97.4x |
| Enterprise Value/EBITDA | 383.6x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does 9544's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 4.1x | ||
4014 Scientific and Medical Equipment House | 2.9x | n/a | ر.س1.5b |
9518 Canadian General Medical Center Complex | 6.2x | n/a | ر.س551.3m |
4007 Al Hammadi Holding | 3.4x | 9.4% | ر.س6.4b |
4009 Middle East Healthcare | 3.8x | 21.4% | ر.س6.4b |
9544 Future Care Trading | 69.3x | n/a | ر.س5.5b |
Price-To-Book vs Peers: 9544 is expensive based on its Price-To-Book Ratio (69.3x) compared to the peer average (4.1x).
Price to Book Ratio vs Industry
How does 9544's PB Ratio compare vs other companies in the SA Healthcare Industry?
| 0 Companies | Price / Book | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Book vs Industry: 9544 is expensive based on its Price-To-Book Ratio (69.3x) compared to the Asian Healthcare industry average (1.8x).
Price to Book Ratio vs Fair Ratio
What is 9544's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 68.5x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate 9544's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.